Guru Ownership Trend
Guru Analysis for Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $49.63 M.
Top institutional holders include Steven Cohen and Paul Tudor Jones.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $38.31 M net outflow during the quarter.
On the selling side, Paul Tudor Jones reduced exposure by 71.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Immunovant, Inc. (IMVT)
Major holders include Steven Cohen ($50.84 M), Paul Tudor Jones ($650,752). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.03 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $38.31 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited IMVT. The total reported sell value was $38.31 M.
No tracked managers opened new positions or increased their holdings in IMVT during the most recent reporting period.